QUESTIONS? CALL (202)-802-8877
- Evans WE, McLeod HL. Pharmacogenomics -- Drug Disposition, Drug Targets, and Side Effect. The New England Journal of Medicine. 2003;348(6):538-549.
- Huang RS, Ratain MJ. Pharmacogenetics and pharmacogenomics of anticancer drugs. CA Cancer J. Clin. 2009;59(1):42–55
- Matthew P. Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy, Clin Pharmacol Ther 2018 May;103(5):770-777
- Black AJ, McLeod HL, Capell HA, et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med. Nov 1 1998;129(9):716-8.
- Birdwell KA, Decker B, Barbarino JM, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing. Clinical Pharmacology and Therapeutics. 2015;98(1):19-24. doi:10.1002/cpt.113
- https://cpicpgx.org/genes-drugs
- https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling